The double-layer sign: In vivo imaging of polypoidal choroidal vasculopathy

Optometry and Vision Science

Volumn 90, Issue 12, 2013, Pages

  St Martin, Jamie M ^a   Rodman, Julie ^a   Pizzimenti, Joseph J ^a   Duchnowski, Eva ^a  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

double layer sign; indocyanine green angiography; optical coherence tomography; polypoidal choroidal vasculopathy; serosanguineous

Indexed keywords

AFRICAN AMERICAN WOMEN; CHOROIDAL NEOVASCULARIZATION; DOUBLE LAYERS; INDOCYANINE GREEN ANGIOGRAPHIES; NEOVASCULAR MEMBRANES; POLYPOIDAL CHOROIDAL VASCULOPATHY; RETINAL PIGMENT EPITHELIAL; SEROSANGUINEOUS;

ANGIOGRAPHY; DIAGNOSIS; PATIENT TREATMENT;

OPTICAL TOMOGRAPHY;

ARTICLE; CASE REPORT; CHOROID; EYE FUNDUS; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; METHODOLOGY; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; POLYP; RETINA DETACHMENT; SCOTOMA; SUBRETINAL NEOVASCULARIZATION; VASCULARIZATION; VISUAL ACUITY; CHOROIDAL NEOVASCULARIZATION; POLYPS; PROCEDURES; RETINAL DETACHMENT;

CHOROID; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HUMANS; MIDDLE AGED; POLYPS; RETINAL DETACHMENT; SCOTOMA; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 84889093230     PISSN: 10405488     EISSN: 15389235     Source Type: Journal    
DOI: 10.1097/OPX.0000000000000079     Document Type: Article

References (21)

1. Gomi F, Tano Y. Polypoidal choroidal vasculopathy and treatments. Curr Opin Ophthalmol 2008;19:208-12.
2. McCleary CD, Guier CP, Dunbar MT. Polypoidal choroidal vasculopathy. Optometry 2004;75:756-70.
3. Sho K, Takahashi K, Yamada H, Wada M, Nagai Y, Otsuji T, Nishikawa M, Mitsuma Y, Yamazaki Y, Matsumura M, Uyama M. Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. Arch Ophthalmol 2003;121:1392-6.
4. Yannuzzi LA. Idiopathic polypoidal choroidal vasculopathy. Paper presented at the Macula Society Meeting, Miami, Florida. February 5, 1982.
5. Freund KB, Zweifel SA, Engelbert M. Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Retina 2010;30:1333-49.
6. Imamura Y, Engelbert M, Iida T, Freund KB, Yannuzzi LA. Polypoidal choroidal vasculopathy: a review. Surv Ophthalmol 2010; 55:501-15.
7. Yannuzzi LA, Freund KB, Goldbaum M, Scassellati-Sforzolini B, Guyer DR, Spaide RF, Maberley D, Wong DW, Slakter JS, Sorenson JA, Fisher YL, Orlock DA. Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy. Ophthalmology 2000;107:767-77.
8. Ahuja RM, Stanga PE, Vingerling JR, Reck AC, Bird AC. Polypoidal choroidal vasculopathy in exudative and haemorrhagic pigment epithelial detachments. Br J Ophthalmol 2000;84:479-84.
9. Tong JP, Chan WM, Liu DT, Lai TY, Choy KW, Pang CP, Lam DS. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol 2006;141:456-62.
10. Kondo N, Honda S, Kuno S, Negi A. Coding variant I62V in the complement factor H gene is strongly associated with polypoidal choroidal vasculopathy. Ophthalmology 2009;116:304-10.
11. Sakurada Y, Kubota T, Mabuchi F, Imasawa M, Tanabe N, Iijima H. Association of LOC387715 A69S with vitreous hemorrhage in polypoidal choroidal vasculopathy. Am J Ophthalmol 2008;145: 1058-62.
12. Zeng R, Wen F, Zhang X, Su Y. Serum levels of matrix metalloproteinase 2 and matrix metalloproteinase 9 elevated in polypoidal choroidal vasculopathy but not in age-related macular degeneration. Mol Vis 2013;19:729-36.
13. Jones A, Kumar S, Zhang N, Tong Z, Yang JH, Watt C, Anderson J, Amrita, Fillerup H, McCloskey M, Luo L, Yang Z, Ambati B, Marc R, Oka C, Zhang K, Fu Y. Increased expression of multifunctional serine protease, HTRA1, in retinal pigment epithelium induces polypoidal choroidal vasculopathy in mice. Proc Natl Acad Sci USA 2011;108:14578-83.
14. Lim TH, Laude A, Tan CS. Polypoidal choroidal vasculopathy: an angiographic discussion. Eye (Lond) 2010;24:483-90.
15. ChanWM, Lai TY. Age-related macular degeneration and polypoidal choroidal vasculopathy in Asia. HKJ Ophthalmology 2010;14:14-9. Available at: http://www.cohk.org.hk/download/V14N1-p14.pdf. Accessed August 16, 2013.
16. Kameda T, Tsujikawa A, Otani A, Sasahara M, Gotoh N, Tamura H, Yoshimura N. Polypoidal choroidal vasculopathy examined with en face optical coherence tomography. Clin Experiment Ophthalmol 2007;35:596-601.
17. Sato T, Kishi S, Watanabe G, Matsumoto H, Mukai R. Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy. Retina 2007;27:589-94.
18. Spaide RF, Yannuzzi LA, Slakter JS, Sorenson J, Orlach DA. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 1995;15:100-10.
19. Lee SY, Kim JG, Joe SG, Chung H, Yoon YH. The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy. Korean J Ophthalmol 2008;22:92-9.
20. Besada E, Shechtman D, Frauens BJ, Reynolds S, Derewyanko D, Vollmer L. Evaluation and management of polypoidal choroidal vasculopathy: case reports and review. Clin Refract Optom 2012; 5:160-70.
21. Lai TY, the EVEREST Study Group. Verteporfin PDT and ranibizumab combination therapy for symptomatic macular polypoidal vasculopathy (PCV): EVEREST results. Invest Ophthalmol Vis Sci 2010;51:E-Abstract 2228.